(1S,2S)-(1-benzyl-3-chloro-2-hydroxypropyl)carbamic acid tert-butyl ester

We are (1S,2S)-(1-benzyl-3-chloro-2-hydroxypropyl)carbamic acid tert-butyl ester CAS:165727-45-7 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:(1S,2S)-(1-Benzyl-3-Chloro-2-Hydroxypropyl)Carbamic Acid Tert-Butyl Ester
CAS.NO:165727-45-7
Synonyms:(1S,2S)-(1-Benzyl-3-Chloro-2-Hydroxypropyl)Carbamic Acid Tert-Butyl Ester
tert-Butyl ((2S,3S)-4-chloro-3-hydroxy-1-phenylbutan-2-yl)carbamate
Molecular Formula:C15H20ClNO3
Molecular Weight:299.79308
 
Specification:
Appearance:White crystalline powder
Assay:≥98.0%
Moisture:≤0.5%
 
Packing:25kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool,ventilated place
Application:Darunavir Intermediates
 

(1S,2S)-(1-benzyl-3-chloro-2-hydroxypropyl)carbamic acid tert-butyl ester


Related News: First of all, as an API manufacturer we think of how to make a chemical compound which becomes an API in the laboratory.dietoxi-metil- (3,3,3-trifluoropropil) silano CAS:118162-95-1 Madeleine Roche, Associate Pharmaceutical Analyst at GlobalData, comments: “Within the top 20 global companies that spent the most on R&D in 2018, the top spender – despite having the second smallest annual revenue of the group at $15.28 billion – is Celgene, whose R&D spend was equal to 37% of its annual revenue.1- (3-metil-1-fenil-1H-pirazol-5-il) piperazina CAS:401566-79-8 Madeleine Roche, Associate Pharmaceutical Analyst at GlobalData, comments: “Within the top 20 global companies that spent the most on R&D in 2018, the top spender – despite having the second smallest annual revenue of the group at $15.28 billion – is Celgene, whose R&D spend was equal to 37% of its annual revenue.327-74-2 At Day 35 following administration, a bone marrow assessment showed that FT819 persisted and continued to demonstrate tumor clearance, whereas primary CAR T cells, while persisting, were not able to control tumor growth.At Day 35 following administration, a bone marrow assessment showed that FT819 persisted and continued to demonstrate tumor clearance, whereas primary CAR T cells, while persisting, were not able to control tumor growth.

Related Products
Product Name
Human ghrelin View Details
3-Chloro-4-Iodopyridine View Details
quinoxalin-2-ol View Details
2-Oxo-1-imidazolidinecarbonyl chloride manufacturer ethyl 2-[(5-tert-butyl-1H-1,2,4-triazol-3-yl)sulfanyl]acetate manufacturer Rhodanine-3-acetic acid manufacturer 2-(4-CHLOROPHENOXY)ANILINE manufacturer 3,5-Difluoropyridine-4-carboxylic acid manufacturer